000 01670 a2200505 4500
005 20250517000347.0
264 0 _c20150421
008 201504s 0 0 eng d
022 _a1931-3543
024 7 _a10.1378/chest.14-1004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFrantz, Robert P
245 0 0 _aHospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational study.
_h[electronic resource]
260 _bChest
_cFeb 2015
300 _a484-494 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Observational Study
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntihypertensive Agents
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHospitalization
_xstatistics & numerical data
650 0 4 _aHumans
650 0 4 _aHypertension, Pulmonary
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultivariate Analysis
650 0 4 _aProspective Studies
650 0 4 _aPyridines
_xtherapeutic use
650 0 4 _aTetrazoles
_xtherapeutic use
650 0 4 _aVasodilator Agents
_xtherapeutic use
700 1 _aSchilz, Robert J
700 1 _aChakinala, Murali M
700 1 _aBadesch, David B
700 1 _aFrost, Adaani E
700 1 _aMcLaughlin, Vallerie V
700 1 _aBarst, Robyn J
700 1 _aRosenberg, Daniel M
700 1 _aMiller, Dave P
700 1 _aHartline, Brian K
700 1 _aBenton, Wade W
700 1 _aFarber, Harrison W
773 0 _tChest
_gvol. 147
_gno. 2
_gp. 484-494
856 4 0 _uhttps://doi.org/10.1378/chest.14-1004
_zAvailable from publisher's website
999 _c24283885
_d24283885